Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of Prosaptide Over 6 Weeks of Treatment for the Relief of Neuropathic Pain Associated With HIV-1

NCT00286377 is registered in ClinicalTrials.gov with Savient Pharmaceuticals as lead sponsor.

NCT NCT00286377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00286377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of Prosaptide Over 6 Weeks of Treatment for the Relief of Neuropathic Pain Associated With HIV-1
Lead sponsor
Savient Pharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2003
Completion date
December 31, 2004
Enrollment
350
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, peripheral nervous system disorders